Merck Beats Quarterly Sales Expectations with Keytruda

The news headline is related to Merck and does not directly affect GOOGL. GOOGL's RSI is at 71.4, approaching overbought territory, suggesting limited upside potential in the short term. Although the MACD is above the signal line, the gap is very narrow, indicating possible weakening momentum. The price is trading above the 20- and 50-day moving averages, maintaining a positive trend, but profit-taking may occur after a 3.3% rise in the last 24 hours. Therefore, due to short-term direction uncertainty, I recommend a neutral outlook.

Merck's Keytruda sales exceeding expectations can be seen as a positive signal for the company's core revenue stream. Technical indicators also support this optimism: the RSI at 55 is in neutral territory but retains upward potential, while the MACD line is near the signal line and in positive territory. The price is trading above the 20- and 50-day moving averages, confirming a short-term uptrend. However, the MACD remaining below the signal line and the last close limited to 113.55 may constrain the pace of the rally. Overall, the news and technical data point to a slight upward trend in the short term.